findmyKOL
Clinical trialNCT00454389UnknownPhase 3Interventional

A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

SponsorNeoVistaEnrollment494Macular Degeneration
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Augenklinik Graz

    Graz, Austria

Germany
  • Klinik Und Poliklinik Für Augenheilkunde Der Universität Leipzig Aör

    Leipzig, Germany

  • Universitätsklinik Und Polyklinik Für Augenkranke

    Würzburg, Germany

Ireland
  • Institute of Clinical Science, Ophthalmic Research Centre, Royal Victoria Hospital

    Belfast, Ireland

Israel
  • Sourasky Medical Center

    Tel Aviv, Israel

Peru
  • Oftalmo Salud Eye Institute

    Lima, Peru

Spain
  • Institutio de Microcirugia Ocular-Barcelona

    Barcelona, Spain

Switzerland
  • University of Geneva

    Geneva, Switzerland

United Kingdom
  • Kings College Hospital

    London, United Kingdom

United States
  • Retinal Consultants of Arizona

    Phoenix, Arizona, United States

  • Retina Center, Pc

    Tucson, Arizona, United States

  • Retina-Vitreous Associates Medical

    Beverly Hills, California, United States

  • Retinal Diagnostic Center

    Campbell, California, United States

  • Northern California Retina Vitreous Associates

    Mountain View, California, United States

  • Ucsf Koret Vision Center

    San Francisco, California, United States

  • Retina Group of Florida

    Fort Lauderdale, Florida, United States

  • Southeast Retina Center

    Augusta, Georgia, United States

  • Retina Institute of Hawaii

    Honolulu, Hawaii, United States

  • Paducah Retinal Center

    Paducah, Kentucky, United States

  • New England Eye Center-Tufts University

    Boston, Massachusetts, United States

  • Associated Retinal Consultants / William Beaumont Hospital

    Royal Oak, Michigan, United States

  • Eye Foundation of Kansas City

    Kansas City, Missouri, United States

  • Charlotte Eye Ear Nose & Throat Associates

    Charlotte, North Carolina, United States

  • Cincinnati Eye Institute

    Cincinnati, Ohio, United States

  • Retina Research Unit of Wills Eye Hospital

    Philadelphia, Pennsylvania, United States

  • Tennessee Retina

    Nashville, Tennessee, United States

  • Austin Retina Associates

    Austin, Texas, United States

  • Retina Research Center

    Austin, Texas, United States

  • Medical Center Ophthalmology Associates

    San Antonio, Texas, United States

  • Retina & Uveitis Consultants of Texas

    San Antonio, Texas, United States

  • Rocky Mountain Retina Consultants

    Salt Lake City, Utah, United States

  • University of Wisconsin

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2007
Primary completion
30 Sept 2011
Completion
31 Aug 2012
Last update posted
27 Jul 2011
Registered enrollment
494
Registry id
NCT00454389

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.